Jack Mozloom News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In the latest episode of the Independent Rx Forum podcast, Jack Mozloom, NCPA vice president of public affairs and marketing, talks to NCPA’s Kaite Krell, associate director of congressional affairs, and Adam Harbison, senior director of congressional affairs, about the legislative landscape. The slate includes NCPA's priorities for independent pharmacies and provides crucial updates on legislation concerning PBM reform and DIR fees.

In the latest episode of the Independent Rx Forum podcast, Jack Mozloom, NCPA vice president of public affairs and marketing, talks to NCPA’s Kaite Krell, associate director of congressional affairs, and Adam Harbison, senior director of congressional affairs, about the legislative landscape. The slate includes NCPA's priorities for independent pharmacies and provides crucial updates on legislation concerning PBM reform and DIR fees.

We want to make it simple for you to catch the conversation between NCPA General Counsel Matthew Seiler and Jack Mozloom, our vice president of public affairs, about the TRUST LLC during our Annual Convention in Orlando. If you prefer podcasts to video, you can now give it a listen here or by searching for “Independent Rx Forum” wherever you tune in. The Independent Rx Forum podcast is a co-production of NCPA and Pharmacy Times.

We’re glad to be returning to your inboxes after a few days away following NCPA’s Annual Convention in Orlando. What a memorable event! qAM threw a lot of information at you during that time, we know (and can you blame us?!), but there are some big things we want to make sure you haven’t missed ...

Fifty states means variety when it comes to policies that impact pharmacy and patient care. Are you up to speed on them? Do you know where the common threads are among states? On the latest episode of Independent Rx Forum, NCPA’s Jack Mozloom is joined by NCPA’s Joel Kurzman and Belawoe Akwakoku from the state government affairs program to discuss how pharmacists can advocate for policy changes at the state level.